References
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
- Maringe C, Walters S, Rachet B, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007. Acta Oncol (Madr). 2013;52:919–932.
- Danish Health and Medicine Authority. Anbefalinger vedrørende screening for tyk- og endetarmskraeft [Recommendations for colorectal cancer screening]. 2012 [cited 2018 May 1].. Available from: https://www.sst.dk/∼/media/1327A2433DDD454C86D031D50FE6D9D6.ashx.
- Ahmed S, Leslie A, Thaha MA, et al. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population. Br J Surg. 2005;92:478–481.
- Rajasekhar PT, Ritchie M, Rutter MD, et al. Lower gastrointestinal symptoms are prevalent among individuals colonoscoped within the Bowel Cancer Screening Programme. Color Dis. 2012;14:e603–e607.
- Vaughan-Shaw PG, Cutting J, Borley N, et al. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer. Colorectal Dis. 2014;16:40–47.
- Hamilton W. Five misconceptions in cancer diagnosis. Br J Gen Pract. 2009;59:441–445.
- Wools A, Dapper EA, de Leeuw JRJ. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26:158–168.
- Frederiksen BL, Jørgensen T, Brasso K, et al. Socioeconomic position and participation in colorectal cancer screening. Br J Cancer. 2010;103:1496–1501.
- Egeberg R, Halkjaer J, Rottmann N, et al. Social inequality and incidence of and survival from cancers of the colon and rectum in a population-based study in Denmark, 1994-2003. Eur J Cancer. 2008;44:1978–1988.
- Pedersen K, Andersen J, Søndergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25:S34–S38.
- Andersen JS, Olivarius NDF, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39:34–37.
- Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39:42–45.
- International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version; 2016. 2016 [cited 2018 May 1]. Available from: http://apps.who.int/classifications/icd10/browse/2016/en#/C15-C26.
- Thomsen MK, Njor SH, Rasmussen M, et al. Validity of data in the Danish Colorectal Cancer Screening Database. Clin Epidemiol. 2017;9:105–111.
- Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30–33.
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
- Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.
- Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39:38–41.
- Statistics Denmark [Internet]. [cited 2018 June 01].Available from: http://www.dst.dk/da/
- UNESCO Institute for Statistics. International Standard Classification of Education. 2011 [cited 2018 May 1]. Available from: http://uis.unesco.org/sites/default/files/documents/international-standard-classification-of-education-isced-2011-en.pdf.
- Bøcker Pedersen C. The Danish Civil Registration System. Scand J Public Health. 2011;39:22–25.
- Garnier Christensen K, Fenger-Grøn M, Rud Flarup K, et al. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis -a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012;12:8.
- Libach Hansen P, Hjertholm P, Vedsted P. Increased diagnostic activity in general practice during the year preceding colorectal cancer diagnosis. Int J Cancer. 2015;137:615–624.
- Campbell SM, Roland MO. Why do people consult the doctor? Fam Pract. 1996;13:75–83.
- Juul JS, Vedsted P. Uncharacteristic colorectal cancer symptoms and their value in general practice. Ugeskr Laeger 2012;174:710–713.
- Högberg C, Karling P, Jörgen R, et al. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: the usefulness of tests for faecal haemoglobin faecal calprotectin. Scand J Gastroenterol. 2017;52:69.
- Mcdonald PJ, Digby J, Innes C, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis. 2013;15:e151–e159.
- Mowat C, Digby J, Strachan JA, et al. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms. Gut 2016;65:1463–1469.
- Kok L, Elias SG, Witteman BJ, et al. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the cost-effectiveness of a decision rule for abdominal complaints in primary care (CEDAR) study. Clin Chem. 2012;58:989–998.